The present invention relates to oral dosage forms of GaQ3 derivatives with an enteric or delayed release coating, wherein said GaQ3 is admixed with a dispersant and in amorphous or nanoparticulate form. The preparation of said oral dosage forms is also disclosed. Such dosage forms are useful for the treatment of disease, including, but not limited to, cancer.